FDA
approval
· 2021-03-05
FDA Approved: BUTORPHANOL TARTRATE — Supplemental Application (Apotex Corp.)
Summary
The FDA approved a supplemental application for butorphanol tartrate from Apotex Corp., updating the product labeling.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for BUTORPHANOL TARTRATE (BUTORPHANOL TARTRATE)